The effects of face masks on cardiopulmonary capacity in healthy young individuals

Autor: Orçin Telli Atalay, Fatma Unver, Erhan Kizmaz

Publikováno v: The Journal of sports medicine and physical fitness. 62(10)

BACKGROUND: Due to the SARS-CoV-2 pandemic that affected the world in a short time, face masks were recommended by all authorities and started to be used widely. Few studies have reported the effects of face masks on cardiopulmonary capacity. In this

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::207d1d72757e717e518146b756155e78
https://pubmed.ncbi.nlm.nih.gov/34821492

Effect of augmented reality books in salivary cortisol levels in hospitalized pediatric patients: A randomized cross-over trial

Autor: Jean P. Tincopa, Daniel Guillén-Pinto, Cesar Carcamo, Nataly Bailon, Dulce E. Alarcón-Yaquetto

Publikováno v: International journal of medical informatics. 148

OBJECTIVE: This study sought to assess the effect of reading augmented reality (AR) books on salivary cortisol levels in hospitalized pediatric patients compared to reading a standard children's book. METHODS: This was a randomized, two-period, cross

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e164aec1d1df6d9f6f25bf202ab015f
https://pubmed.ncbi.nlm.nih.gov/33581476

Optimal Sampling Strategies for Therapeutic Drug Monitoring of First-Line Tuberculosis Drugs in Patients with Tuberculosis

Autor: Jos G. W. Kosterink, Yanri Wijayanti Subronto, Antonia Morita Iswari Saktiawati, Sumardi, Marcel Harkema, Rob E. Aarnoutse, Althaf Setyawan, Marieke G G Sturkenboom, Ymkje Stienstra, Jan-Willem C. Alffenaar, Cecile Magis-Escurra, Tjip S. van der Werf

Publikováno v: Clinical Pharmacokinetics, 58, 1445-1454
Clinical Pharmacokinetics, 58, 11, pp. 1445-1454
Clinical Pharmacokinetics, 58(11), 1445-1454. Springer International Publishing AG
Clinical Pharmacokinetics

BACKGROUND: The 24-h area under the concentration-time curve (AUC24)/minimal inhibitory concentration ratio is the best predictive pharmacokinetic/pharmacodynamic (PK/PD) parameter of the efficacy of first-line anti-tuberculosis (TB) drugs. An optima

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b8b422d54aac4f6c0d21f71fbde0f3f
http://hdl.handle.net/2066/212269

Pharmacokinetics and Tolerability of Once Daily Double Dose Tobramycin Inhalation in Cystic Fibrosis Using Controlled and Conventional Nebulization

Autor: Aukje C. Bos, Daan J Touw, Hettie M. Janssens, Harry G.M. Heijerman, A.J. Van Velzen, Harm A.W.M. Tiddens

Publikováno v: Journal of Aerosol Medicine and Pulmonary Drug Delivery, 29(3), 273-280. Mary Ann Liebert Inc.
Journal of aerosol medicine and pulmonary drug delivery, 29(3), 273-280. MARY ANN LIEBERT, INC

Background: Better treatment outcomes in cystic fibrosis (CF) may be expected by changing standard twice daily (BID) tobramycin inhalation with the conventional nebulizer to once daily (OD) inhalation at double the standard BID dose with a controlled

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a624feca6cf3ed8f5d3d1b611e733ec5
https://doi.org/10.1089/jamp.2015.1259

Association between hazard ratios of surrogate time-to-event endpoints and overall survival in advanced/metastatic cancers

Autor: Gebregergish, S., Hashim, M., Bartsch, R., Ouwens, M.J., Postma, M.J., Heeg, B.

Publikováno v: None

Objectives: Surrogate endpoints can support early access to novel therapies. In trial-level endpoint validation studies, the association between treatment effect e.g., the hazard ratio (HR) on both the surrogate and hard endpoint can be estimated. We

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::96bf5408962f8db8c46e35188379a7ec
https://research.rug.nl/en/publications/0c2ad17c-bb53-4826-b5c1-6b74cfd53f55